Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy-Reference-Cited by-同舟云学术

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy

Published:2013-01 Issue: Volume:415 Page:63-68
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Bosselut Nelly,Taibi Ludmia,Guéchot Jérôme,Zarski Jean-Pierre,Sturm Nathalie,Gelineau Marie-Christine,Poggi Bernard,Thoret Sophie,Lasnier Elisabeth,Baudin Bruno,Housset Chantal,Vaubourdolle Michel

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference29 articles.

1. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the study of the Liver (AFEF);Cadranel;Hepatology,2000

2. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection;Regev;Am J Gastroenterol,2002

3. Sampling variability of liver fibrosis in chronic hepatitis C;Bedossa;Hepatology,2003

4. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis;Sandrin;Ultrasound Med Biol,2003

5. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C;Ziol;Hepatology,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis;Lung;2024-04-20

2. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

3. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline;Hepatology;2024-03-15

4. Osteoprotegerin is an early marker of the fibrotic process and of antifibrotic treatment responses in ex vivo lung fibrosis;2024-02-02

5. Serum biomarkers for liver fibrosis;Clinica Chimica Acta;2022-12